- Home
- MDRR vs LSTA Comparison
MDRR vs LSTA Comparison
Compare MDRR & LSTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDRR
- LSTA
- Stock Information
- Founded
- MDRR 2015
- LSTA 1980
- Country
- MDRR United States
- LSTA United States
- Employees
- MDRR N/A
- LSTA N/A
- Industry
- MDRR Real Estate Investment Trusts
- LSTA Misc Health and Biotechnology Services
- Sector
- MDRR Real Estate
- LSTA Health Care
- Exchange
- MDRR Nasdaq
- LSTA Nasdaq
- Market Cap
- MDRR 18.0M
- LSTA 20.9M
- IPO Year
- MDRR 2018
- LSTA N/A
- Fundamental
- Price
- MDRR $13.00
- LSTA $2.31
- Analyst Decision
- MDRR
- LSTA Strong Buy
- Analyst Count
- MDRR 0
- LSTA 2
- Target Price
- MDRR N/A
- LSTA $23.50
- AVG Volume (30 Days)
- MDRR 663.0
- LSTA 140.1K
- Earning Date
- MDRR 11-11-2025
- LSTA 11-06-2025
- Dividend Yield
- MDRR 2.08%
- LSTA N/A
- EPS Growth
- MDRR N/A
- LSTA N/A
- EPS
- MDRR N/A
- LSTA N/A
- Revenue
- MDRR $9,649,145.00
- LSTA $1,070,000.00
- Revenue This Year
- MDRR N/A
- LSTA N/A
- Revenue Next Year
- MDRR N/A
- LSTA N/A
- P/E Ratio
- MDRR N/A
- LSTA N/A
- Revenue Growth
- MDRR N/A
- LSTA N/A
- 52 Week Low
- MDRR $9.55
- LSTA $1.87
- 52 Week High
- MDRR $15.00
- LSTA $4.20
- Technical
- Relative Strength Index (RSI)
- MDRR 47.68
- LSTA 41.59
- Support Level
- MDRR $13.01
- LSTA $2.00
- Resistance Level
- MDRR $13.45
- LSTA $2.98
- Average True Range (ATR)
- MDRR 0.13
- LSTA 0.23
- MACD
- MDRR -0.11
- LSTA -0.03
- Stochastic Oscillator
- MDRR 28.57
- LSTA 31.63
About MDRR Medalist Diversified REIT Inc.
Medalist Diversified REIT Inc is engaged to acquire, reposition, renovate, lease, and manage income-producing properties with a focus on commercial properties, including flex-industrial and retail properties, multi-family residential properties, and hotel properties. The company operates as a UPREIT and owns properties through its subsidiary, Medalist Diversified Holdings, LP. Its reportable segments were retail center properties, flex center properties, and STNL properties.
About LSTA Lisata Therapeutics Inc.
Lisata Therapeutics Inc is a clinical-stage pharmaceutical company dedicated to the discovery, development, and commercialization of therapies for the treatment of solid tumors and other diseases. Its investigational product, certepetide, is designed to activate a novel uptake pathway that allows co-administered or tethered (i.e., molecularly bound) anti-cancer drugs to target and penetrate solid tumors more effectively. The group has one operating segment, the research and development of its investigational drug product.